62.92 USD
↘ 1.42 (2.21%)AT CLOSE (11:59 AM EDT)
Tarsus Pharmaceuticals, Inc. Common Stock
TARSNASDAQ • USD
62.85
↘ 0.07 (0.11%)
POST MARKET (AS OF 07:11 PM EDT)
Post Market
AS OF 07:11 PM EDT
62.85
↘ 0.07 (0.11%)
Market: CLOSED
Tarsus Pharmaceuticals, Inc. Common Stock (TARS) trades at $62.92 per share. The technical outlook is "Buy" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place TARS at a fair price relative to peers.
Technical & fundamental data as of Jun 26, 2026.
Open?$64.64
High?$66.50
Low?$60.72
Prev. Close?$64.34
Volume?2.0M
Avg. Volume?697.3K
VWAP?$63.01
Rel. Volume?2.90x
Bid / Ask
Bid?$55.00 × 200
Ask?$62.66 × 200
Spread?$7.66
Midpoint?$58.83
Valuation & Ratios
Market Cap?2.7B
Shares Out?43.0M
Float?36.7M
Float %?86.2%
P/E Ratio?N/A
P/B Ratio?7.76
EPS?-$1.13
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.
Employees
370
Market Cap
2.8B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2020-10-16
Address
15440 LAGUNA CANYON ROAD
IRVINE, CA 92618
Phone: (949) 409-9820
IRVINE, CA 92618
Phone: (949) 409-9820
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?100
Momentum?97
Short Sent.?54
Piotroski F-Score?4/9Mixed
Altman Z-Score?7.40Safe
Confidence?63%Moderate
Short InterestHigh
Short % of Float?13.58%High
Short Interest?5.0M
Days to Cover?8.9
Free Float36.7M
Avg Daily Volume559.3K
Settlement Date2026-06-15
Financial Health
Current Ratio?3.74Strong
Quick Ratio?3.71Strong
Cash Ratio?0.71Adequate
Debt/Equity?0.21Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score75/100
P/E?N/A▾
P/B?7.76FAIR▾
Peers100
S&P24
P/S?5.06FAIR▾
Peers100
S&P29
P/FCF?N/A▾
EV/EBITDA?-48.4CHEAP▾
S&P97
EV/Sales?5.00FAIR▾
Peers100
S&P36
Returns & Efficiency
ROE?-14.0%WEAK▾
S&P9
ROA?-8.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-31539000
Enterprise Value?$2.7B
Fundamentals ratios updated end of day